# RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

> **NCT00193856** · PHASE3 · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 1071 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Leuprorelin Acetate
- **DRUG:** Zoledronic Acid
- **RADIATION:** Conventional external beam therapy

## Key facts

- **NCT ID:** NCT00193856
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 1071 (ACTUAL)
- **Last updated:** 2017-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00193856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00193856, "RADAR Trial - Randomised Androgen Deprivation and Radiotherapy". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00193856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*